
Prostate-specific antigen (PSA) testing has been a cornerstone of prostate cancer screening for decades. In November 2026, the American Cancer Society (ACS) released updated screening recommendations driven by growing evidence that early detection saves lives.
Unlike its 2010 guidelines, which simply advised men to talk with their physicians about whether to be screened, the ACS now directly recommends routine PSA testing.
The New ACS Screening Recommendations
The updated guidelines break down screening schedules by age and risk level:
- Men at average risk (ages 50–69): Undergo a PSA blood test every two years starting at age 50.
- Men at higher risk: Black men and men with a strong family history of prostate cancer (such as a father or brother diagnosed before age 65, or multiple close relatives with the disease) should get an annual PSA test from age 45 through 69.
- Men ages 70–74: Talk with your physician to weigh the pros and cons of continuing PSA screening.
- Men age 75 and older: Routine screening is typically not advised, though exceptionally healthy men between ages 75 and 79 might still benefit from testing after consulting their doctor.
Personalized Care at Michigan Institute of Urology
At Michigan Institute of Urology, our physicians tailor prostate cancer screening to each individual. As urology specialists, we follow clinical guidelines from the American Urological Association (AUA) and the National Comprehensive Cancer Network (NCCN). These organizations support starting baseline screening even earlier for many patients, beginning at age 45 for most men and as early as age 40 for those at higher risk.
Your testing frequency depends on your age, family history, genetic risk factors, general health, and prior PSA results. Depending on your profile, you may need annual screening, or you may be able to safely test less frequently.
The PSA test itself is a straightforward blood draw. While a high PSA level can be a sign of prostate cancer, benign conditions like inflammation or an enlarged prostate can also raise your numbers. An elevated result does not automatically mean you have cancer or require a biopsy. Often, your doctor will repeat the PSA test to verify the reading. Based on your results and personal risk factors, a prostate MRI or specialized blood and urine biomarker tests can help clarify your risk and prevent unnecessary biopsies.
Is the Digital Rectal Exam Still Necessary?
Historically, a digital rectal exam (DRE) was routinely paired with a PSA test. During a DRE, a physician uses a gloved, lubricated finger to check the prostate through the rectum for abnormalities in texture, shape, or size.
Under the revised ACS guidelines, a DRE is no longer recommended as part of routine screening. Your physician may still perform a physical prostate exam if you are experiencing urinary symptoms or if your PSA levels are elevated.
Deciding When to Stop Screening
Many prostate cancers develop very slowly and may never cause symptoms or threaten a man’s life. As men age, doctors must balance the potential benefits of catching a cancer early against the risks of overtesting and overtreatment. Routine screening is generally discouraged for men who have major health issues or a life expectancy under 10 years.
Age is just one factor in that decision. At Michigan Institute of Urology, we frequently continue screening healthy men into their 70s and beyond, evaluating their overall health, life expectancy, past PSA trends, and personal wishes.
Schedule Your Conversation Today
Early prostate cancer often causes no symptoms. Ask your MIU clinician when PSA screening makes sense for you based on your age, family history, and overall health.
Learn more about prostate cancer screening and treatment at Michigan Institute of Urology.

